Publication & Citation Trends
Publications
0 total
Clinical development of galunisertib (LY2157299 monohydrate), a small molecule inhibitor of transforming growth factor-beta signaling pathway OA
Cited by 536
Semantic Scholar
Clinical development of galunisertib ( LY 2157299 monohydrate ) , a small molecule inhibitor of transforming growth factorbeta factorbeta factorbeta signaling pathway
Cited by 1
Semantic Scholar
Optimization of a dihydropyrrolopyrazole series of transforming growth factor-beta type I receptor kinase domain inhibitors: discovery of an orally bioavailable transforming growth factor-beta receptor type I inhibitor as antitumor agent.
Cited by 61
Semantic Scholar
A Concise Synthesis of Quinazolinone TGF-β RI Inhibitor Through One-Pot Three-Component Suzuki—Miyaura/Etherification and Imidate—Amide Rearrangement Reactions.
Cited by 0
Semantic Scholar
Imidazolidinonylaminopyrimidin compounds for treating cancer
Cited by 0
Semantic Scholar
Research Topics
Chemical Synthesis and Reactions
(11)
Asthma and respiratory diseases
(8)
TGF-β signaling in diseases
(8)
Chemical Synthesis and Analysis
(6)
Asymmetric Synthesis and Catalysis
(5)
Affiliations
Harvard University
Eli Lilly (United States)
Vanderbilt University
Albany Molecular Research (United States)
International Union for Conservation of Nature